Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
The purpose of the Connect™ Chronic Lymphocytic Leukemia (CLL) Disease Registry is to explore
 the history and real world management of patients diagnosed with CLL, provide insight into
 the management of CLL, and evaluate the effectiveness of first, second and subsequent
 therapeutic strategies employed in both the community and academic settings.
Inclusion Criteria:

 -  Clinical diagnosis with CLL

 -  Clinical decision made to initiate first-line therapy, second-line therapy or
 subsequent line of therapy prior to enrollment into the ConnectTM CLL registry, but
 within 2 months of enrollment

 -  Age≥18 years

 -  Willing and able to provide signed informed consent

 -  Willing and able to complete patient assessment questionnaires either alone or with
 minimal assistance from caregivers and/or trained site personnel

 Exclusion Criteria:

 -  Participation in a clinical study in which study treatment is blinded

 -  Patient condition is considered terminal (i.e.<6 months to live)